Correlation Between Processa Pharmaceuticals and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Processa Pharmaceuticals and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Processa Pharmaceuticals and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Pmv Pharmaceuticals.
Diversification Opportunities for Processa Pharmaceuticals and Pmv Pharmaceuticals
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Processa and Pmv is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Processa Pharmaceuticals and Pmv Pharmaceuticals
Given the investment horizon of 90 days Processa Pharmaceuticals is expected to generate 2.12 times more return on investment than Pmv Pharmaceuticals. However, Processa Pharmaceuticals is 2.12 times more volatile than Pmv Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 1,440 in Processa Pharmaceuticals on August 31, 2024 and sell it today you would lose (1,324) from holding Processa Pharmaceuticals or give up 91.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Processa Pharmaceuticals vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Processa Pharmaceuticals |
| Pmv Pharmaceuticals |
Processa Pharmaceuticals and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Processa Pharmaceuticals and Pmv Pharmaceuticals
The main advantage of trading using opposite Processa Pharmaceuticals and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Processa Pharmaceuticals vs. Alpha Cognition | Processa Pharmaceuticals vs. Acurx Pharmaceuticals LLC | Processa Pharmaceuticals vs. Fennec Pharmaceuticals | Processa Pharmaceuticals vs. SAB Biotherapeutics |
| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |